Images List Premium Download Classic

Glycosaminoglycan

Glycosaminoglycan-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Cartilage compositions and methods for modifying proteoglycan content
Isto Technologies, Inc.
December 21, 2017 - N°20170360989

The present disclosure relates to cartilage repair compositions and methods for modifying the proteoglycan content of the compositions. Specifically, the methods relate to serum free, collagen free neocartilage made from chondrocytes that can be used for implants. Proteoglycans, such as aggrecan and sulfated glycosaminoglycan are used and the content modified using temperature changes.
Glycosaminoglycan-based materials as an engineered biocompatible cellular matrix
Purdue Research Foundation
December 14, 2017 - N°20170354758

Disclosed herein is a cross-linked polymeric system comprising thiolated hyaluronic acid (ha), thiolated chondroitin sulfate (cs), and functionalized polyethylene glycol (peg), wherein said functionalized peg cross-links thiolated ha and thiolated cs. Methods of fabrication and utilization of the same are also claimed. This polymeric system may be used as an engineered biocompatible cellular matrix for 3d cell culture, tissue engineering ...
Determination of glycosaminoglycan levels by mass spectrometry
Shire Human Genetic Therapies, Inc.
December 07, 2017 - N°20170350900

Detecting glycosaminoglycans (gags) and/or determining the level of one or more glycosaminoglycans can be useful, e. G., in identifying or monitoring various medical conditions, the status of patients having various medical conditions, and/or the response to treatment of individuals having various medical conditions. The present invention provides methods for detecting glycosaminoglycans and/or determining the level of glycosaminoglycans ...
Glycosaminoglycan Patent Pack
Download + patent application PDFs
Glycosaminoglycan Patent Applications
Download + Glycosaminoglycan-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Glycosaminoglycan-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Peptide and complex of same, scaffold for tissue repair and surface treatment method for same, ...
Jms Co., Ltd.
November 16, 2017 - N°20170327539

A peptide that enables surface treatment of a scaffold for tissue repair that makes it possible to accelerate the repair of living tissue without using a material that negatively affects the repair of living tissue, a complex containing this peptide, a scaffold for tissue repair surface treated using this peptide or this complex, a surface treatment method for a scaffold ...
Pharmaceutical extracts and uses thereof
November 02, 2017 - N°20170312305

The invention provides an isolated extract comprising glycosaminoglycans from whelk and/or cockle species.
Composition containing glycosaminoglycans and proteins
October 19, 2017 - N°20170296698

A composition comprising polyhydroxyurethanes, glycosaminoglycans, hydrolysed glycosaminoglycans, glycosamines of glycosaminoglycans, chemically modified or not and a protein or a peptide; said protein being collagen, elastin, keratin, fibronectin, actin, myosin, laminin, a peptide or a blend of those proteins or peptides, fibrillated, hydrolysed, chemically modified or not. This homogenous composition is obtained by the polymerisation or the covalent bounding of two ...
Glycosaminoglycan Patent Pack
Download + patent application PDFs
Glycosaminoglycan Patent Applications
Download + Glycosaminoglycan-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Glycosaminoglycan-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Cancer biomarkers
Chalmers Ventures Ab
September 07, 2017 - N°20170254811

The present invention relates to a method of screening for renal cell carcinoma in a subject, said method comprising determining the level and/or chemical composition of one or both of the glycosaminoglycans (gags) chondroitin sulfate (cs) and heparan sulfate (hs) in a body fluid sample, wherein said sample has been obtained from said subject.
Soluble hyaluronidase glycoprotein (shasegp), process for preparing the same, uses and pharmaceutical compositions comprising thereof
Halozyme, Inc.
August 31, 2017 - N°20170246264

Provided are soluble neutral active hyaluronidase glycoproteins (shasegp's), methods of manufacture, and their use to facilitate administration of other molecules or to alleviate glycosaminoglycan associated pathologies. Minimally active polypeptide domains of the soluble, neutral active shasegp domains are described that include asparagine-linked sugar moieties required for a functional neutral active hyaluronidase domain. Included are modified amino-terminal leader peptides that enhance ...
Stabilized glycosaminoglycan preparations and related methods
S.k. Pharmaceuticals, Inc.
August 24, 2017 - N°20170239287

Compositions comprising a glycosaminoglycan (e. G., a hyaluronan, hyaluronic acid, hyaluronate, sodium hyaluronate, dermatan sulfate, karatan sulfate, chondroitin 6-sulfate, heparin, etc.) in combination with at least one component selected from; i) polyglycols (e. G., polyethylene glycol), ii) long chain hydroxy polyanionic polysaccharides (e. G., dextran, sodium alginate, alginic acid, propylene glycol alginate, carboxymethyl cellulose and carboxyethyl cellulose, hydroxyl ethyl starch, ...
Development of magnetic-micro particles that provide controlled glycosaminoglycan (gag) release and the intravesical usage of ...
August 24, 2017 - N°20170239285

Disclosed is the production of glycosaminoglycan covered with magnetic nanoparticles, with nanotechnology to be used in the repair of glycosaminoglycan layer that is damaged in the bladder due to interstitial cystitis.
Polymeric materials including a glycosaminoglycan networked with a polyolefin-containing polymer
Colorado State University Research Foundation
July 06, 2017 - N°20170189583

The present invention relates to polymeric materials including a glycosaminoglycan networked with a polyolefin-containing polymer. The present invention also relates to hydrogels containing the polymeric materials. The present invention further relates to methods of synthesizing the polymeric materials and hydrogels of the present invention.
Hemostatic compositions
Biom'up
July 06, 2017 - N°20170189499

The invention relates to a hemostatic composition in powder form comprising collagen of the fibrillar type comprising a content of fibrous collagen and/or fibrillar collagen of at least 70% by weight relative to the total weight of the collagen, and at least one monosaccharide, and optionally, at least one compound selected from coagulation factors and glycosaminoglycans. The invention further relates ...
Wound care treatment and methods of making and using same
Nutech Spine, Inc.
June 29, 2017 - N°20170182216

A method of treating a wound including applying a wound care treatment to the wound, the wound care treatment including a preparation composed of morselized amnion tissue and amniotic fluid cells adsorbed to a porous collagen matrix and optionally, glycosaminoglycan. The morselized amnion tissue includes organized amniotic extracellular matrix (ecm), amniotic tissue cells and growth factors contained within the ecm ...
Glycosaminoglycan Patent Pack
Download + patent application PDFs
Glycosaminoglycan Patent Applications
Download + Glycosaminoglycan-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Glycosaminoglycan-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Composition for tissue/cell repair
June 22, 2017 - N°20170173119

The composition for tissue/cell repair facilitates healing of damaged tissues, promoting tissue and cell growth, protecting cells and tissues, and reducing scar tissue. The composition includes hydrolyzed collagen, and may include high molecular weight hydrolyzed collagen. The hydrolyzed collagen may be combined with native collagen and/or at least one other therapeutic agent. For example, the therapeutic agent may ...
Method of manufacturing an implantable film and prothesis comprising such a film
Sofradim Production
June 15, 2017 - N°20170165399

A method for manufacturing an implantable film and a prosthesis comprising such a film the present invention relates to a method for manufacturing a non porous film intended to be implanted in the human body, said method comprising the following steps: preparation of a first film, called intermediate film, via gelling of a starting solution comprising at least one polymer ...
Compound of glycosaminoglycan and its fabrication method as well as application
Holy Stone Healthcare Co., Ltd.
June 01, 2017 - N°20170151336

The present invention is related to a compound conjugating a drug with a glycosaminoglycan, such as hyaluronic acid (ha), where the drug is useful for the treatment of diseases such as inflammation, auto-immune disease, allergy, infection and preferably cancer. The conjugated compound of the present invention can increase the concentration of drug at the specific site of disease by an ...
Method for in vivo production of glycosaminoglycans
Universite Grenoble Alpes
May 18, 2017 - N°20170137857

The present invention relates to a method for in vivo production of glycosaminoglycans (gag), by metabolic engineering in a genetically modified cell. In a method according to the invention, said cell is genetically modified in order to express the genes coding for the enzymes that are suitable for synthesising gag from an exogenous precursor, preferably internalised by the cell. According ...
Liposomal formulations for delivery of nucleic acids
Ramot At Tel-aviv University Ltd.
May 11, 2017 - N°20170128367

There are provided liposomes, comprising cationic lipids, a membrane stabilizing lipid and at least one lipid conjugated to a polyethylene glycol (peg) derivative, in particular peg-amine, the liposomes are coated with a glycosaminoglycan, in particular, hyaluronic acid (ha), compositions comprising the same, methods for their preparation and uses thereof for the efficient delivery of nucleic acids, such as, si rna ...
Glycosaminoglycans
Agency For Science, Technology And Research
April 20, 2017 - N°20170106012

Heparan sulphate hs/bmp2 is disclosed, together with the use of hs/bmp2 in the repair and regeneration of bone tissue.
Topical formulations for increasing the dermal concentration of hyaluronic acid
Shamroc, Inc.
March 30, 2017 - N°20170087178

Described herein are methods and compositions for increasing dermal concentrations of glycosaminoglycans (gag), including hyaluronic acid. Exemplary methods involve a one-step protocol and a three-step protocol. Either method can be used over a 90-day treatment period.
Ocular formulations
Encompass Development, Inc.
March 30, 2017 - N°20170087117

Compositions and methods for providing anesthesia to the eye, for treating or preventing inflammatory disorders in the eye, or for treating or preventing ocular infections, are disclosed. The compositions include a glycosaminoglycan, such as hyaluronic acid, in a concentration suitable for achieving a desired viscosity, as well as an active agent, such as an anesthetic, anti-inflammatory, antimicrobial, antiproliferative, antimetabolite, prostaglandin, ...
Loading